News & Updates

Show Multimedia Only
Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19

Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19

07 Jul 2023

In the treatment of patients with mild-to-moderate COVID-19, adding fluvoxamine to favipiravir does not appear to prevent disease progression or improve certain outcomes, according to the results of an open-label study.

07 Jul 2023
More evidence for COVID-19 vaccine safety in kids

More evidence for COVID-19 vaccine safety in kids

05 Jul 2023

COVID-19 vaccines can be safely administered in children, with a recent study showing that out of the numerous health outcomes monitored in near real time, the safety signal identified was for only myocarditis or pericarditis.

05 Jul 2023